v3 Template
N

Navega Therapeutics

Biotechnology
Founded
--
Employees
--
Total Funding
$4.0M
Funding Rounds
1
Last Funding
2025-02-04

About Navega Therapeutics

Navega Therapeutics is focused on harnessing the precision of zinc-finger and CRISPR-based epigenome regulation to develop next-generation gene therapies, particularly for chronic pain and precision pain management.

Products & Services

Gene Therapies for Chronic Pain:Developing advanced gene therapies targeting chronic pain using epigenome regulation technologies.
Precision Pain Management:Innovative solutions for precise pain management through cutting-edge genetic technologies.

Specialties

Zinc-finger technology CRISPR-based epigenome regulation Gene therapies Chronic pain management Precision pain solutions

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Translational Science Grant
T: -
FT: Translational Science Grant 		A: 4000000
MR: -
FA: $4M
FAN: 4000000 		D: 2025-02-04
FD: 2025-02-04 		1 investors
Translational Science Grant Latest
2025-02-04
$4.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Navega Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro